Provision of long-term monitoring and late effects services following adult allogeneic haematopoietic stem cell transplant: a survey of UK NHS-based programmes

[1]  J. Snowden,et al.  Late treatment effects following bone marrow transplant: Efficacy of implementing international guidelines , 2018, European journal of cancer care.

[2]  A. Pickard,et al.  Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease. , 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[3]  A. Tichelli,et al.  Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  S. Bhatia.  Caring for the long-term survivor after allogeneic stem cell transplantation. , 2014, Hematology. American Society of Hematology. Education Program.

[5]  J. Antin,et al.  Hematopoietic stem cell transplantation donor sources in the 21st century: choosing the ideal donor when a perfect match does not exist. , 2014, Blood.

[6]  H. Einsele,et al.  High prevalence of distress in patients after allogeneic hematopoietic SCT: Fear of progression is associated with a younger age , 2014, Bone Marrow Transplantation.

[7]  S. Bhatia,et al.  Burden of morbidity in 10+ year survivors of hematopoietic cell transplantation: report from the bone marrow transplantation survivor study. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[8]  N. Majhail,et al.  Surviving the cure: long term followup of hematopoietic cell transplant recipients , 2013, Bone Marrow Transplantation.

[9]  Stephanie J. Lee,et al.  Delivering care to long-term adult survivors of hematopoietic cell transplantation. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  M. Suarez‐Almazor,et al.  Late effects and healthcare needs of survivors of allogeneic stem cell transplantation: a qualitative study , 2012, BMJ Supportive & Palliative Care.

[11]  J. Wingard,et al.  First- and second-line systemic treatment of acute graft-versus-host disease: recommendations of the American Society of Blood and Marrow Transplantation. , 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[12]  M. Aljurf,et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. , 2012, Biology of Blood and Marrow Transplantation.

[13]  C. Bloomfield,et al.  Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission. , 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[14]  N. Majhail.  Secondary cancers following allogeneic haematopoietic cell transplantation in adults , 2011, British journal of haematology.

[15]  M. Sorror,et al.  Long-term survival and late deaths after allogeneic hematopoietic cell transplantation. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[16]  Hermann Einsele,et al.  Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective , 2009, Biology of Blood and Marrow Transplantation.

[17]  J. Snowden,et al.  Follow-up care for cancer survivors: the views of clinicians , 2009, British Journal of Cancer.

[18]  J. Snowden,et al.  Follow-up care for cancer survivors: views of the younger adult , 2009, British Journal of Cancer.

[19]  Yuelin Li,et al.  Barriers to Mental Health Service Use among Hematopoietic Stem Cell Transplant Survivors , 2009, Bone Marrow Transplantation.

[20]  J. Snowden,et al.  Ovarian failure following cancer treatment: current management and quality of life. , 2008, Human reproduction.

[21]  A. Nademanee,et al.  Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study. , 2007, Blood.

[22]  A. Gratwohl,et al.  Premature cardiovascular disease after allogeneic hematopoietic stem-cell transplantation. , 2007, Blood.

[23]  J. Wingard,et al.  Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation: joint recommendations of the European Group for Blood and Marrow Transplantation, Center for International Blood and Marrow Transplant Research, and the American Society for Blood and Mar , 2006, Bone Marrow Transplantation.

[24]  R. Gatti,et al.  Immunological reconstitution of sex-linked lymphopenic immunological deficiency. , 1968, Lancet.

[25]  J. Snowden,et al.  Routine vaccination practice after adult and paediatric allogeneic haematopoietic stem cell transplant: a survey of UK NHS programmes , 2017, Bone Marrow Transplantation.

[26]  M. Norkin,et al.  Quality of life, social challenges, and psychosocial support for long-term survivors after allogeneic hematopoietic stem-cell transplantation. , 2012, Seminars in hematology.

[27]  Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. , 2009, Bone marrow transplantation.